Arterial blood pressure and baroreflex sensitivity 1-18 years after completing anthracycline therapy

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

NOVÁKOVÁ Zuzana BALCÁRKOVÁ Pavla HONZÍKOVÁ Nataša FIŠER Bohumil ZÁVODNÁ Eva HRSTKOVÁ Hana KRONTORÁDOVÁ Klára ŠŤASTNÁ Jana

Year of publication 2007
Type Article in Periodical
Magazine / Source Neoplasma
MU Faculty or unit

Faculty of Medicine

Citation
Field Physiology
Keywords anthracycline; baroreflex sensitivity; blood pressure; cardiotoxicity
Description The analysis of short-term blood pressure regulation in children, adolescents and young adults 1 to 18 years after the treatment with anthracyclines with cardiotoxic side effects for oncological diseases was the aim of the present study. Thirty-one subjects treated with anthracyclines (PA) and 11 subjects treated with different antitumour drugs (P0) were investigated twice (the interval between two investigations 1 - 9 years). Three hundred and thirty-nine healthy subjects served as controls (C). We concluded (according our results) that the anthracycline antitumour therapy in children decreases blood pressure and within 18 years after the treatment there is not observed a trend toward normal values. BRS was not influenced by the anthracycline therapy.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.